Showing 9721-9730 of 20328 results for "".
- Quantitative PET/MRI Framework to Identify LATEhttps://reachmd.com/news/quantitative-petmri-framework-to-identify-late/2485854/An abstract on LATE describes a quantitative 18F-FDG PET– and MRI-volumetry–based framework intended to help identify LATE
- Pre‑Exposure Intranasal Neomycin and Influenza B Transmission: Animal Model Findingshttps://reachmd.com/news/preexposure-intranasal-neomycin-and-influenza-b-transmission-animal-model-findings/2485863/Controlled influenza B transmission experiments in two animal models tested pre-exposure intranasal neomycin sulfate, with outcomes described as differin
- WHO Recommendations for 2026–2027 Northern Hemisphere Influenza Vaccine Compositionhttps://reachmd.com/news/who-recommendations-for-20262027-northern-hemisphere-influenza-vaccine-composition/2485870/The World Health Organization (WHO) reported its recommended viral composition
- Boosters Restore SARS‑CoV‑2 Immunity in Kidney Transplant Recipientshttps://reachmd.com/news/boosters-restore-sarscov2-immunity-in-kidney-transplant-recipients/2485853/In the RECOVAC study, investigators compared kidney transplant recipients (KTRs) who seroconverted after primary vaccination with those who se
- Polyphenol Interventions and Bifidobacterium: Key Findings from a Recent Systematic Reviewhttps://reachmd.com/news/polyphenol-interventions-and-bifidobacterium-key-findings-from-a-recent-systematic-review/2485861/A full systematic review and meta-analysis synthesizes human dietary polyphenol intervention studies that assessed changes in gut microbiota, highlightin
- Study: Bimekizumab Not Linked to Higher Depression Risk vs. IL-23 Inhibitorshttps://reachmd.com/news/study-bimekizumab-not-linked-to-higher-depression-risk-vs-il-23-inhibitors/2485849/Bimekizumab was not associated with increased risk of depression or suicidal ideation compared with IL-23 inhibitors, a new study from George Washington University indicated. "Bimekizumab, a dual IL-17A/F inhibitor, has demons
- Analysis: Tapinarof Cream Yields Improved Sleep in Pediatric ADhttps://reachmd.com/news/analysis-links-tapinarof-cream-to-early-sleep-improvements-in-pediatric-ad/2485802/A new analysis of the phase 3 ADORING 1 and ADORING 2 trials showed that tapinarof cream, 1% (VTAMA, Organon) was associated with early and sustained improvements in sleep-related patient-reported outcomes in pediatric patients with moderate to severe atopic derma
- Dermatologic Infections After Migration Through Latin Americahttps://reachmd.com/news/dermatologic-infections-after-migration-through-latin-america/2485848/An abstract in JAMA Dermatology reports dermatologic infections after migration through Latin America, describ
- Nutrition, Insulin Resistance, and Platelet Hyperactivity: Reporting Key Findingshttps://reachmd.com/news/nutrition-insulin-resistance-and-platelet-hyperactivity-reporting-key-findings/2485839/A recent review describes insulin resistance (IR) as accompanied by platelet hyperactivity and a broader prothrombotic milieu, and it outlines nutrition-related links to platelet and vascular pat
- Early Lipid and Inflammatory Changes After Upadacitinib in Biologic‑Refractory SpAhttps://reachmd.com/news/early-lipid-and-inflammatory-changes-after-upadacitinib-in-biologicrefractory-spa/2485837/In a retrospective real-world cohort of biologic-refractory spondyloarthritis, investigators reported that starting upadacitinib was followed by a rapid, parallel pattern over the first three mon